Trials / Enrolling By Invitation
Enrolling By InvitationNCT05160480
A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 9 (estimated)
- Sponsor
- University of California, Davis · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to test new ways to improve the usefulness of the world's first total-body positron emission tomography (PET)/computed tomography (CT) scanner (EXPLORER) by collecting data from PET scans using one of three different imaging agents: 18F-PSMA; 18F-FES; or, 68Ga DOTATATE. These imaging agents are approved by the FDA to be used for patients diagnosed with prostate cancer (18F-PSMA), neuroendocrine tumor (68Ga DOTATATE), or breast cancer (18F-FES).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Total-body PET imaging | Total-body PET imaging at different timepoints |
Timeline
- Start date
- 2024-06-07
- Primary completion
- 2026-09-01
- Completion
- 2026-09-01
- First posted
- 2021-12-16
- Last updated
- 2026-03-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05160480. Inclusion in this directory is not an endorsement.